Diabetic Dyslipidemia Beyond Conventional Lipid Profiles: Molecular Mechanisms, Emerging Biomarkers and Novel Therapeutic Strategies
Diabetic dyslipidemia is a complex metabolic abnormality characterized by hypertriglyceridemia, reduced high-density lipoprotein cholesterol (HDL-C), qualitative abnormalities of low-density lipoprotein (LDL) particles, and accumulation of triglyceride-rich lipoproteins (TRLs) and their remnants. Although LDL cholester...